Recombinant fusion protein of human LYPD1(NP_653187.3).
Conjugation:
Unconjugated
Alternative Names:
LYPD1,LYPDC1,PHTS
Believed to act as a modulator of nicotinic acetylcholine receptors (nAChRs activity. In vitro increases receptor desensitization and decreases affinity for ACh of alpha-4:beta-2-containing nAChRs. May play a role in the intracellular trafficking of alpha-4:beta-2 and alpha-7-containing nAChRs and may inhibit their expression at the cell surface. May be involved in the control of anxiety.
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Form:
1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Application Dilute:
WB,1:1000 - 1:2000
Application Notes:
Unmodification
* VAT and and shipping costs not included. Errors and price changes excepted
